- Home
- Publications
- Publication Search
- Publication Details
Title
Mucosal vaccines for SARS-CoV-2: triumph of hope over experience
Authors
Keywords
-
Journal
EBioMedicine
Volume 92, Issue -, Pages 104585
Publisher
Elsevier BV
Online
2023-05-03
DOI
10.1016/j.ebiom.2023.104585
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Protective effectiveness of previous SARS-CoV-2 infection and hybrid immunity against the omicron variant and severe disease: a systematic review and meta-regression
- (2023) Niklas Bobrovitz et al. LANCET INFECTIOUS DISEASES
- Infectiousness of SARS-CoV-2 breakthrough infections and reinfections during the Omicron wave
- (2023) Sophia T. Tan et al. NATURE MEDICINE
- SARS-CoV-2 breakthrough infection induces rapid memory and de novo T cell responses
- (2023) Marios Koutsakos et al. IMMUNITY
- Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis
- (2023) Caroline Stein et al. LANCET
- Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection
- (2022) Victoria Hall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Intranasal COVID-19 vaccines: From bench to bed
- (2022) Aqu Alu et al. EBioMedicine
- Lung-resident memory B cells established after pulmonary influenza infection display distinct transcriptional and phenotypic profiles
- (2022) Hyon-Xhi Tan et al. Science Immunology
- Secondary influenza challenge triggers resident memory B cell migration and rapid relocation to boost antibody secretion at infected sites
- (2022) Andrew J. MacLean et al. IMMUNITY
- Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis
- (2022) Ryan M Barber et al. LANCET
- Risk of SARS-CoV-2 reinfection and COVID-19 hospitalisation in individuals with natural and hybrid immunity: a retrospective, total population cohort study in Sweden
- (2022) Peter Nordström et al. LANCET INFECTIOUS DISEASES
- Systemic and mucosal IgA responses are variably induced in response to SARS-CoV-2 mRNA vaccination and are associated with protection against subsequent infection
- (2022) Salma Sheikh-Mohamed et al. Mucosal Immunology
- Infectious viral load in unvaccinated and vaccinated individuals infected with ancestral, Delta or Omicron SARS-CoV-2
- (2022) Olha Puhach et al. NATURE MEDICINE
- Respiratory Mucosal Immunity: Kinetics of Secretory Immunoglobulin A in Sputum and Throat Swabs From COVID-19 Patients and Vaccine Recipients
- (2022) Cuiping Ren et al. Frontiers in Microbiology
- Safety and immunogenicity of a live-attenuated influenza virus vector-based intranasal SARS-CoV-2 vaccine in adults: randomised, double-blind, placebo-controlled, phase 1 and 2 trials
- (2022) Fengcai Zhu et al. Lancet Respiratory Medicine
- A live attenuated virus-based intranasal COVID-19 vaccine provides rapid, prolonged, and broad protection against SARS-CoV-2
- (2022) Junyu Chen et al. Science Bulletin
- Serological Follow-Up Study Indicates High Seasonal Coronavirus Infection and Reinfection Rates in Early Childhood
- (2022) Pekka Kolehmainen et al. Microbiology Spectrum
- Viral infection engenders bona fide and bystander subsets of lung-resident memory B cells through a permissive mechanism
- (2022) Claude Gregoire et al. IMMUNITY
- SARS-CoV-2 breakthrough infection in vaccinees induces virus-specific nasal-resident CD8+ and CD4+ T cells of broad specificity
- (2022) Joey Ming Er Lim et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Effects of Previous Infection and Vaccination on Symptomatic Omicron Infections
- (2022) Heba N. Altarawneh et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial
- (2022) Jing-Xin Li et al. Lancet Respiratory Medicine
- Mucosal administration of a live attenuated recombinant COVID-19 vaccine protects nonhuman primates from SARS-CoV-2
- (2022) Mariana F. Tioni et al. npj Vaccines
- Respiratory mucosal immunity against SARS-CoV-2 following mRNA vaccination
- (2022) Jinyi Tang et al. Science Immunology
- Long-primed germinal centres with enduring affinity maturation and clonal migration
- (2022) Jeong Hyun Lee et al. NATURE
- Protection against Omicron from Vaccination and Previous Infection in a Prison System
- (2022) Elizabeth T. Chin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Anti-Spike Mucosal IgA Protection against SARS-CoV-2 Omicron Infection
- (2022) Sebastian Havervall et al. NEW ENGLAND JOURNAL OF MEDICINE
- Unadjuvanted intranasal spike vaccine elicits protective mucosal immunity against sarbecoviruses
- (2022) Tianyang Mao et al. SCIENCE
- Tolerability and immunogenicity of an intranasally-administered adenovirus-vectored COVID-19 vaccine: An open-label partially-randomised ascending dose phase I trial
- (2022) Meera Madhavan et al. EBioMedicine
- Viral load dynamics of SARS-CoV-2 Delta and Omicron variants following multiple vaccine doses and previous infection
- (2022) Yonatan Woodbridge et al. Nature Communications
- SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination
- (2022) Felicity Liew et al. EBioMedicine
- A prospective surveillance study on the kinetics of the humoral immune response to the respiratory syncytial virus fusion protein in adults in Houston, Texas
- (2021) Brittani N. Blunck et al. VACCINE
- Tissue-resident CD4+ T helper cells assist the development of protective respiratory B and CD8+ T cell memory responses
- (2021) Young Min Son et al. Science Immunology
- T resident helper cells promote humoral responses in the lung
- (2021) Nivedya Swarnalekha et al. Science Immunology
- Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection
- (2021) David S. Khoury et al. NATURE MEDICINE
- mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection
- (2021) Leonidas Stamatatos et al. SCIENCE
- Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose
- (2021) Catherine J. Reynolds et al. SCIENCE
- Seroprevalence and SARS-CoV-2 cross-reactivity of endemic coronavirus OC43 and 229E antibodies in Finnish children and adults
- (2021) Kirsi Tamminen et al. CLINICAL IMMUNOLOGY
- Safety, tolerability, and immunogenicity of an aerosolised adenovirus type-5 vector-based COVID-19 vaccine (Ad5-nCoV) in adults: preliminary report of an open-label and randomised phase 1 clinical trial
- (2021) Shipo Wu et al. LANCET INFECTIOUS DISEASES
- Peripheral and lung resident memory T cell responses against SARS-CoV-2
- (2021) Judith Grau-Expósito et al. Nature Communications
- Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
- (2021) Shuo Feng et al. NATURE MEDICINE
- A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses
- (2021) Weina Sun et al. Nature Communications
- Safety and Immunogenicity Analysis of a Newcastle Disease Virus (NDV-HXP-S) Expressing the Spike Protein of SARS-CoV-2 in Sprague Dawley Rats
- (2021) Johnstone Tcheou et al. Frontiers in Immunology
- Mucosal immune response in BNT162b2 COVID-19 vaccine recipients
- (2021) Lorenzo Azzi et al. EBioMedicine
- SARS-CoV-2 infection generates tissue-localized immunological memory in humans
- (2021) Maya M.L. Poon et al. Science Immunology
- Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination
- (2021) Alberto Cagigi et al. JCI Insight
- Immune-mediated attenuation of influenza illness after infection: opportunities and challenges
- (2021) Manish M Patel et al. Lancet Microbe
- IgA subclasses have different effector functions associated with distinct glycosylation profiles
- (2020) Ulrike Steffen et al. Nature Communications
- Direct Observation of Repeated Infections With Endemic Coronaviruses
- (2020) Marta Galanti et al. JOURNAL OF INFECTIOUS DISEASES
- Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics
- (2020) Jack Mellors et al. Frontiers in Immunology
- A Single-Dose Intranasal ChAd Vaccine Protects Upper and Lower Respiratory Tracts against SARS-CoV-2
- (2020) Ahmed O. Hassan et al. CELL
- Compromised Humoral Functional Evolution Tracks with SARS-CoV-2 Mortality
- (2020) Tomer Zohar et al. CELL
- Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
- (2020) Merryn Voysey et al. LANCET
- Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate
- (2020) Weina Sun et al. EBioMedicine
- Live Attenuated and Inactivated Influenza Vaccine Effectiveness
- (2019) Jessie R. Chung et al. PEDIATRICS
- Estimating the annual attack rate of seasonal influenza among unvaccinated individuals: A systematic review and meta-analysis
- (2018) Mitchell P. Somes et al. VACCINE
- Vaccine failure and serologic response to live attenuated and inactivated influenza vaccines in children during the 2013–2014 season
- (2018) Jennifer P. King et al. VACCINE
- Immune responses after live attenuated influenza vaccination
- (2018) Kristin G.-I. Mohn et al. Human Vaccines & Immunotherapeutics
- The establishment of resident memory B cells in the lung requires local antigen encounter
- (2018) S. Rameeza Allie et al. NATURE IMMUNOLOGY
- CD4+ Memory T Cells at Home in the Tissue: Mechanisms for Health and Disease
- (2018) David Schreiner et al. Frontiers in Immunology
- Human Tissue-Resident Memory T Cells Are Defined by Core Transcriptional and Functional Signatures in Lymphoid and Mucosal Sites
- (2017) Brahma V. Kumar et al. Cell Reports
- 2014–2015 Influenza Vaccine Effectiveness in the United States by Vaccine Type
- (2016) Richard K. Zimmerman et al. CLINICAL INFECTIOUS DISEASES
- Live Attenuated Influenza Vaccine in Children Induces B-Cell Responses in Tonsils
- (2016) Kristin Greve-Isdahl Mohn et al. JOURNAL OF INFECTIOUS DISEASES
- Relationship of the quaternary structure of human secretory IgA to neutralization of influenza virus
- (2015) Tadaki Suzuki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CD4+ T Cell Help Guides Formation of CD103+ Lung-Resident Memory CD8+ T Cells during Influenza Viral Infection
- (2014) Brian J. Laidlaw et al. IMMUNITY
- Resident memory CD8 T cells trigger protective innate and adaptive immune responses
- (2014) J. M. Schenkel et al. SCIENCE
- Transcriptional downregulation of S1pr1 is required for the establishment of resident memory CD8+ T cells
- (2013) Cara N Skon et al. NATURE IMMUNOLOGY
- Memory B cells in the lung participate in protective humoral immune responses to pulmonary influenza virus reinfection
- (2012) T. Onodera et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cutting Edge: Tissue-Retentive Lung Memory CD4 T Cells Mediate Optimal Protection to Respiratory Virus Infection
- (2011) J. R. Teijaro et al. JOURNAL OF IMMUNOLOGY
- Structure and function relationships in IgA
- (2011) J M Woof et al. Mucosal Immunology
- Mucins in the mucosal barrier to infection
- (2008) S K Linden et al. Mucosal Immunology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started